2Morrow
2Morrow is a digital therapeutics company delivering evidence-based, ACT-grounded behavior change programs via smartphone to employers, states, and health plans, addressing tobacco cessation, chronic pain, stress, weight, and sleep, with over 1 million users served since 2012.
- Company typePrivate
- Founded2011
- HeadquartersKirkland, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What 2Morrow does
2Morrow is a digital behavioral health company that develops and distributes evidence-based digital therapeutics (DTx) and wellness programs through its proprietary 2Morrow Health smartphone platform. Founded in 2011 in Kirkland, Washington by a registered nurse and a medical device engineer, the company delivers programs grounded in Acceptance and Commitment Therapy (ACT) — a third-wave cognitive behavioral therapy approach exclusively licensed from Fred Hutchinson Cancer Research Center. The platform offers bundled programs addressing tobacco cessation (SmartQuit, iCanQuit, vaping cessation), chronic pain management (Salty), stress and anxiety, weight management, sleep, and grief/loss, all accessible through a single app with optional in-app coaching and peer group features.
The company operates a multi-channel B2B go-to-market targeting large employers, state public health agencies, and health plans through enterprise licensing contracts, supplemented by direct-to-consumer one-time purchases via Walmart.com, platform integration partnerships (Spring Health, FIT HR), and pilot referral programs with telehealth providers (98point6). Revenue is generated primarily through enterprise subscription contracts (per-employee/per-member annual licensing), direct digital sales, and platform licensing arrangements. The company holds SOC 2 Type 2 and HIPAA/HITECH compliance certifications and received the inaugural DiMe Seal (2025) for clinical evidence quality.
2Morrow firmographics
Firmographics- Name
- 2Morrow
- Legal name
- 2Morrow, Inc.
- Website
- https://2morrowinc.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- 2Morrow is a digital therapeutics company delivering evidence-based, ACT-grounded behavior change programs via smartphone to employers, states, and health plans, addressing tobacco cessation, chronic pain, stress, weight, and sleep, with over 1 million users served since 2012.
- Ownership category
- akta.pro rank
2Morrow industry classification
Industry- Product category
- Digital Behavioral Health Therapeutics
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Condition-specific Digital Therapeutics (DTx) (HLACANAA)
- akta.pro secondary industries
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI), Non-prescription / OTC Digital Therapeutics (HLACANAC), Pediatrics & Adolescent Therapeutics (Digital) (HLACANAL), Women’s Health & Fertility Therapeutics (Digital) (HLACANAK), DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)
Keywords
Where 2Morrow is headquartered
LocationHeadquarters
- HQ city
- Kirkland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
2Morrow business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Enterprise B2B Licensing: 2Morrow licenses its digital health programs to large employers, health plans, and state governments. Programs are offered as employee/statesman benefits through enterprise contracts. Revenue derived from per-employee/per-member licensing fees or bundled wellness program contracts.
- Direct-to-Consumer Digital Sales: One-time purchase of digital programs available via Walmart.com. Programs sold directly to consumers without subscription requirement. Also available free through state public health programs and special initiatives (wildfire relief, healthcare worker support).
- Platform Integration Licensing: Integration of 2Morrow programs into partner platforms (e.g., Spring Health). Partner distributes 2Morrow's tobacco cessation program as part of comprehensive mental health solution. Revenue share or licensing arrangement with platform partners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | One-time digital purchase for individual consumers |
| Subscription | Annual | Enterprise licensing for employers and health plans |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels6 records
2Morrow product offering
Product offeringCore offering
2Morrow provides evidence-based digital therapeutic (DTx) and wellness programs delivered through its 2Morrow Health smartphone app and web platform. Programs are grounded in Acceptance and Commitment Therapy (ACT), with technology exclusively licensed from Fred Hutchinson Cancer Research Center. Offerings address tobacco cessation, chronic pain, stress, weight management, grief/loss, and sleep, organized into bundles (Breathe, Wellbeing, Resolve) and standalone programs sold to employers, states, and health plans, and directly to consumers via Walmart.com.
Product overview
2Morrow is a digital behavioral health company offering evidence-based wellness and digital therapeutic programs through its 2Morrow Health platform. The company provides a portfolio of interconnected programs organized into three bundles: the Wellbeing Bundle (focusing on mind-body connection), Resolve Bundle (behavioral health for life challenges), and Breathe Bundle (tobacco cessation with related support). Individual programs include tobacco cessation (SmartQuit, iCanQuit, Vaping Cessation), Salty for Chronic Pain (NIH-funded ACT-based program), weight management, stress/anxiety, grief/loss/change, and sleep. All programs are accessible via the same smartphone app and grounded in Acceptance and Commitment Therapy (ACT) principles. The company distributes through employers, states, health plans, and wellness platforms.
Differentiator
Problem solved
Functional benefit
Brands
- 2Morrow Health: Primary digital health platform offering evidence-based wellness programs for tobacco cessation, stress management, weight management, chronic pain, and behavioral health support
- Salty for Chronic Pain
- SmartQuit
- iCanQuit
- Vital
Products and services
- 2Morrow Health Primary digital therapeutic platform delivering multiple evidence-based behavior modification programs via smartphone app, with enterprise dashboard and API integrations for clients. All programs are accessible through the same app.
- Breathe Bundle Holistic tobacco cessation bundle with extra support for related concerns and behaviors. Awarded DiMe Seal 2025. Includes programs for tobacco cessation, stress, weight, and personal goal setting.
- Wellbeing Bundle Bundled program connecting a healthy mind and body, starting with what matters most to the user. Part of the 2Morrow Health platform.
- Resolve Bundle Bundled program offering behavioral health and wellness strategies to cope with life's challenges and foster personal growth. Part of the 2Morrow Health platform.
- Salty for Chronic Pain NIH-funded digital behavioral health program for chronic pain management grounded in Acceptance and Commitment Therapy (ACT). Peer-reviewed program guiding users through 58 structured lessons covering physical, emotional, social, and values-based dimensions of living with pain.
- Tobacco Programs Evidence-based tobacco cessation programs including SmartQuit and iCanQuit for smoking, vaping cessation for teens and young adults, and programs for quitting while pregnant. Grounded in ACT principles with coaching support.
- Vital: A Companion App for People Living with Cancer Free mobile app designed in partnership with Washington State Department of Health to help cancer survivors learn and practice skills to support their cancer journey and recovery.
- Weight Management Program Digital behavioral program addressing weight management using ACT principles to help users deal with unhelpful thoughts, feelings, and urges that keep them stuck in old patterns.
- Stress (and Anxiety) Program Digital behavioral program for stress and anxiety management using Acceptance and Commitment Therapy to improve coping skills.
- Grief, Loss, and Change Program Digital program helping people cope with grief, loss, and life changes. Features lessons and exercises in noticing thoughts, emotions, and feelings that are difficult to control, as well as taking valued actions toward health and self-care.
Quantifiable outcome
- 50% higher quit rates at 12 months vs standard apps
- +4 more outcomes
Companies that use 2Morrow
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
2Morrow technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
2Morrow partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights6 records
2Morrow competitors and assessment
Company assessmentDirect peers
- Pelago (formerly Quit Genius): Pelago is the closest direct peer: an enterprise digital therapeutics company specializing in tobacco, vaping, and substance use cessation sold to employers, health plans, and providers. It overlaps directly with 2Morrow's tobacco cessation franchise, employer GTM motion, and clinical-evidence-led positioning.
- Click Therapeutics: Click Therapeutics develops prescription and OTC digital therapeutics across smoking cessation, depression, migraine, and other indications, sold through payer and pharma channels. It is comparable to 2Morrow in being a multi-condition DTx platform with a clinical-trial-led commercialization model targeting health plans and employers.
- Big Health: Big Health sells digital therapeutics for insomnia (Sleepio) and anxiety (Daylight) to employers and health plans, with FDA-clearance and large-RCT evidence. It is directly comparable to 2Morrow on behavioral health DTx for self-insured employers, B2B enterprise GTM, and RCT-grade clinical positioning.
- Akili Interactive: Akili is a prescription digital therapeutics company with FDA-cleared products in cognitive and behavioral health, distributed via pharmacy and provider channels. Comparable to 2Morrow as a clinically validated, condition-specific DTx company pursuing regulated, evidence-led commercialization.
Broad incumbents
- Headspace: Headspace for Work is a broad incumbent in employer-sold behavioral health, offering meditation, mindfulness, therapy, and coaching under one platform. It is comparable to 2Morrow on enterprise wellness GTM and behavioral health content, but covers a wider mental wellness surface area and competes for the same benefits-budget dollars.
- Calm Business: Calm Business sells mindfulness, sleep, and mental wellness apps to employers as part of broader consumer wellness platform. Comparable as a broad incumbent competing for the same employer wellness budget and consumer mindshare as 2Morrow's stress, sleep, and grief/loss programs.
- Omada Health: Omada Health is an established virtual-care and digital therapeutics company addressing diabetes, hypertension, and behavioral health, sold to employers, health plans, and pharmacy benefit managers. Comparable to 2Morrow as a chronic-condition DTx platform with employer/health plan distribution and payer-aligned economics.
Emerging players
- Happify Health: Happify Health offers digital therapeutics and wellbeing programs for stress, anxiety, depression, and chronic conditions, distributed through employers, health plans, and pharma partnerships. Comparable to 2Morrow as an evidence-based behavioral DTx platform targeting the same enterprise buyer.
- Wysa: Wysa provides AI-driven behavioral health coaching and self-guided CBT/ACT-based programs to employers, health plans, and health systems. Comparable to 2Morrow on the ACT/CBT digital therapy methodology and the enterprise wellness GTM, though more AI-conversation-led.
- WellDoc: WellDoc develops FDA-cleared digital therapeutics for diabetes and other chronic conditions, sold to health plans, employers, and pharmacy benefit managers. Comparable to 2Morrow as a regulated, clinically validated DTx company pursuing reimbursement in chronic disease management.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Customer concentration
2Morrow social profiles
Digital presence2Morrow compliance and trust
Trust signalCompliance3 records
2Morrow financial estimates
Financial estimateRevenue estimate
Valuation estimate
2Morrow leadership team
Management profileNumber of profiles
Profiles5 records
2Morrow funding detail
Funding detailFunding overview
Funding rounds7 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
2Morrow M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 2Morrow
What does 2Morrow do?
2Morrow provides evidence-based digital therapeutic (DTx) and wellness programs delivered through its 2Morrow Health smartphone app and web platform. Programs are grounded in Acceptance and Commitment Therapy (ACT), with technology exclusively licensed from Fred Hutchinson Cancer Research Center. Offerings address tobacco cessation, chronic pain, stress, weight management, grief/loss, and sleep, organized into bundles (Breathe, Wellbeing, Resolve) and standalone programs sold to employers, states, and health plans, and directly to consumers via Walmart.com.
Is 2Morrow a public or private company?
2Morrow is a private company. It is classified as venture growth investor backed and is currently operating.
When was 2Morrow founded?
2Morrow was founded in 2011. It employs 11 to 50 people.
Where is 2Morrow based?
2Morrow is headquartered in Kirkland, United States, in the North America region.
How does 2Morrow make money?
Three revenue lines are on record. Enterprise B2B Licensing is the primary driver. The others are direct-to-Consumer Digital Sales and platform Integration Licensing.
Who are 2Morrow's main competitors?
Direct peers on record are Pelago (formerly Quit Genius), Click Therapeutics, Big Health and Akili Interactive. Broad incumbents are Headspace, Calm Business and Omada Health. Emerging players are Happify Health, Wysa and WellDoc.
Does 2Morrow have an API?
No public API is recorded for 2Morrow.
What industry is 2Morrow in?
2Morrow's product category is Digital Behavioral Health Therapeutics. Its primary akta.pro industry code is HLACANAA, Condition-specific Digital Therapeutics (DTx), with a secondary code of HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its NAICS code is 621420 and its SIC code is 8000.